Search research articles
Contact Us
Filters
Showing results (1-10 of 209) with videos related to
Page
of 21
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 15, 2011
A novel protein degradation system in young-onset Parkinson's disease: mitophagy is a therapeutic target as a quality control for damaged mitochondria
Taku Hatano
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 26, 2013
Induced pluripotent stem cells can be a useful disease model for understanding the pathomechanisms of PARK2
Taku Hatano
Rinsho Shinkeigaku = Clinical Neurology
|
January 27, 2012
[Up to date on Parkinson's disease --therapy]
Taku Hatano
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 18, 2013
PINK1 autophosphorylation facilitates Parkin recruitment to mitochondria: new insight in the mechanisms of quality control for mitochondria in young-onset Parkinson's disease
Taku Hatano
Neurology
|
December 12, 2025
Toward a Biological Understanding of Tauopathies: Insights From Plasma and Imaging Biomarkers
Taku Hatano
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
January 20, 2026
[Fall Risk and Its Management in Parkinson's Disease]
Taku Hatano, Hikaru Kamo
Expert Review of Neurotherapeutics
|
January 19, 2016
What is NODDI and what is its role in Parkinson's assessment?
Koji Kamagata, Taku Hatano, Shigeki Aoki
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
August 24, 2007
[Clinical molecular genetics for PARK8 (LRRK2)]
Hiroyuki Tomiyama, Taku Hatano, Nobutaka Hattori
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
June 10, 2024
[Mechanisms Underlying the Propagation of α-Synuclein Seeds Derived from the Blood of Patients with α-Synucleinopathies]
Ayami Okuzumi, Taku Hatano, Nobutaka Hattori
International Journal of Molecular Sciences
|
December 9, 2023
The Role of Immune Dysfunction in Parkinson's Disease Development
Davide Cossu, Taku Hatano, Nobutaka Hattori
Page
of 21
Search research articles
Search
Showing results (1-10 of 209) with videos related to
Sort By:
Page
of 21
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 15, 2011
A novel protein degradation system in young-onset Parkinson's disease: mitophagy is a therapeutic target as a quality control for damaged mitochondria
Taku Hatano
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 26, 2013
Induced pluripotent stem cells can be a useful disease model for understanding the pathomechanisms of PARK2
Taku Hatano
Rinsho Shinkeigaku = Clinical Neurology
|
January 27, 2012
[Up to date on Parkinson's disease --therapy]
Taku Hatano
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 18, 2013
PINK1 autophosphorylation facilitates Parkin recruitment to mitochondria: new insight in the mechanisms of quality control for mitochondria in young-onset Parkinson's disease
Taku Hatano
Neurology
|
December 12, 2025
Toward a Biological Understanding of Tauopathies: Insights From Plasma and Imaging Biomarkers
Taku Hatano
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
January 20, 2026
[Fall Risk and Its Management in Parkinson's Disease]
Taku Hatano, Hikaru Kamo
Expert Review of Neurotherapeutics
|
January 19, 2016
What is NODDI and what is its role in Parkinson's assessment?
Koji Kamagata, Taku Hatano, Shigeki Aoki
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
August 24, 2007
[Clinical molecular genetics for PARK8 (LRRK2)]
Hiroyuki Tomiyama, Taku Hatano, Nobutaka Hattori
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
June 10, 2024
[Mechanisms Underlying the Propagation of α-Synuclein Seeds Derived from the Blood of Patients with α-Synucleinopathies]
Ayami Okuzumi, Taku Hatano, Nobutaka Hattori
International Journal of Molecular Sciences
|
December 9, 2023
The Role of Immune Dysfunction in Parkinson's Disease Development
Davide Cossu, Taku Hatano, Nobutaka Hattori
Page
of 21